33 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.
University of Tennessee Health Science Center
Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23S-Dihydroxyvitamin D3 and Its 23R Epimer.
University of Tennessee Health Science Center
Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.
University of Tennessee Health Science Center
Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).
University of Tennessee Health Science Center
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
University of Tennessee Health Science Center
Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.
University of Tennessee Health Science Center
Structural studies of pterin-based inhibitors of dihydropteroate synthase.
University of Tennessee Health Science Center
Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
University of Tennessee Health Science Center
Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.
University of Tennessee Health Science Center
Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.
University of Tennessee Health Science Center
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer.
University of Tennessee Health Science Center
EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.
University of Tennessee Health Science Center
Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.
University of Tennessee Health Science Center
Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.
University of Tennessee Health Science Center
Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.
University of Tennessee Health Science Center
Synthesis and biological evaluation of selective survivin inhibitors derived from the MX-106 hydroxyquinoline scaffold.
University of Tennessee Health Science Center
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression.
University of Tennessee Health Science Center
Design, synthesis, molecular modeling studies, and calpain inhibitory activity of novel alpha-ketoamides incorporating polar residues at the P1'-position.
University of Tennessee Health Science Center
Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer.
University of Tennessee Health Science Center
Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
University of Tennessee Health Science Center
Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-189.
University of Tennessee Health Science Center
DPAGT1 Inhibitors of Capuramycin Analogues and Their Antimigratory Activities of Solid Tumors.
University of Tennessee Health Science Center
Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer.
University of Tennessee Health Science Center
Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors.
University of Tennessee Health Science Center
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity.
University of Tennessee Health Science Center
Structure-Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties.
University of Tennessee Health Science Center
Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors.
University of Tennessee Health Science Center
Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.
University of Tennessee Health Science Center
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors.
University of Tennessee Health Science Center
Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents.
University of Tennessee Health Science Center
